News Focus
News Focus
icon url

BonelessCat

03/03/14 11:24 AM

#55522 RE: govorchin #55520

Agree. And Brilacidin Phase 2b is now filling enrollment and dosing, and for at least 2 weeks now.
icon url

tootalljones

03/03/14 11:52 AM

#55524 RE: govorchin #55520

People are not paying attention, and if I were Leo......

Every week of no news is great news for Kevetrin. We will be dosing Cohort 8 inside of a month, How about 225 mg at cohort 8 of Kevetrin? We received unexpected news of efficacy signals at less than 1/4 of this dosage. The market will not put 2 and 2 together until we get something announced.....so this would appear to be a terrific buy window for savy investors.

If I were Leo and Dr. M, I would not ask anybody for a Board position until we announced some sort of preview or interim results in the Kevetrin trial. This bait will attract the truly big fish or two to bite. I believe Leo is all over this issue.
icon url

TheMonolith

03/03/14 12:04 PM

#55525 RE: govorchin #55520

Is there any evidence available to the public about K causing shrinkage, or is it simply by word?